injections of 100 nmol kg 1 GLP-1MK-801 ( n = 8 mice and n = 4 cages), 300 nmol kg 1 GLP-1MK-801 ( n = 8 mice and n = 4 cages) or vehicle (isotonic saline, n = 8 mice and n = 4 cages) for 14 days
und der Bestandteil (b) ein Salz von L-Carnitin oder Alkanoyl-L-carnitin mit Pamosure mit der allgemeinen Formel (I) enthlt.The invention described herein comprises also a composition that is used to cover the daily Needs of L-carnitine and / or an alkanoyl-L-carnitine, wherein the alkanoyl has 2 to 6 carbon atoms to an individual who such treatment is needed is suitable, partially comprising the L-carnitine and / or alkanoyl-L-carnitine (a) in a free, readily available form and in part (b) in a form that ensures controlled release, thereby characterized in that the Component (a) L-carnitine or alkanoyl-L-carnitine in the form of internal salts or contains pharmacologically acceptable hydrosoluble salts
It mimics the effects of GLP-1, a hormone that regulates blood sugar levels and appetite
GHK-Cu primarily modulates gene expression related to extracellular matrix turnover, collagen synthesis, and cellular resilience
conchigera rhizome (Taib et al., 2020)
